canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet
- RxCUI
- 1545164
- RxNorm name
- canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet
- Display name
- canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet
- Full name
- canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INVOKAMET | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Janssen Pharmaceuticals, Inc. | 6868666b-c25e-40d1-9d1f-306bbe9390c1 | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | 1545164 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6868666b-c25e-40d1-9d1f-306bbe9390c1 | canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet | SCD | 31 | These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014 | 20250821 |
| 6868666b-c25e-40d1-9d1f-306bbe9390c1 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | PSN | 31 | These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014 | 20250821 |